Related Experiment Video
Updated: Dec 8, 2025
Generation of a RIP1 Knockout U937 Cell Line Using the CRISPR-Cas9 System
Published on: April 11, 2025
25 years of research put RIPK1 in the clinic
1The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria 3052, Australia; Department of Medical Biology, University of Melbourne, Parkville, Victoria 3050, Australia.
Abstract:
Receptor Interacting Protein Kinase 1 (RIPK1) is a key regulator of inflammation. To warrant cell survival and appropriate immune responses, RIPK1 is post-translationally regulated by ubiquitylations, phosphorylations and caspase-8-mediated cleavage. Dysregulations of these post-translational modifications switch on the pro-death function of RIPK1 and can cause inflammatory diseases in humans. Conversely, activation of RIPK1 cytotoxicity can be advantageous for cancer treatment. Small molecules targeting RIPK1 are under development for the treatment of cancer, inflammatory and neurogenerative disorders. We will discuss the molecular mechanisms controlling the functions of RIPK1, its pathologic role in humans and the therapeutic opportunities in targeting RIPK1, specifically in the context of inflammatory diseases and cancers.
Insights
Receptor Interacting Protein Kinase 1 (RIPK1) regulates inflammation and cell death. Targeting RIPK1 offers therapeutic potential for inflammatory diseases and cancers by modulating its complex functions.
Area of Science:
- Molecular biology
- Immunology
- Pharmacology
Background:
- Receptor Interacting Protein Kinase 1 (RIPK1) is a critical regulator of inflammatory pathways.
- RIPK1 activity is controlled by post-translational modifications, including ubiquitylation, phosphorylation, and caspase-8 cleavage.
- Dysregulation of RIPK1 modifications can lead to inflammatory diseases or be exploited for cancer therapy.
Purpose of the Study:
- To elucidate the molecular mechanisms governing RIPK1 functions.
- To explore the pathological role of RIPK1 in human diseases.
- To discuss therapeutic strategies targeting RIPK1 for inflammatory and cancerous conditions.
Main Methods:
- Review of molecular mechanisms controlling RIPK1.
- Analysis of RIPK1's role in human pathology.
- Discussion of RIPK1-targeting small molecules and their therapeutic applications.
Main Results:
- RIPK1's dual role in promoting cell survival and initiating cell death is highlighted.
- Post-translational modifications are key determinants of RIPK1's functional output.
- Aberrant RIPK1 activity is implicated in various inflammatory diseases.
Conclusions:
- Understanding RIPK1 regulation is crucial for developing treatments for inflammatory disorders.
- Targeting RIPK1 presents a promising therapeutic avenue for cancer treatment.
- RIPK1 modulation offers potential for treating neurodegenerative diseases as well.
More Related Videos
13:34Method for the Isolation and Identification of mRNAs, microRNAs and Protein Components of Ribonucleoprotein Complexes from Cell Extracts using RIP-Chip
Published on: September 29, 2012
09:15Tyramide Signal Amplification for the Immunofluorescent Staining of ZBP1-Dependent Phosphorylation of RIPK3 and MLKL After HSV-1 Infection in Human Cells
Published on: October 20, 2022